Nyxoah SA (NASDAQ:NYXH) Short Interest Update

Nyxoah SA (NASDAQ:NYXH - Get Free Report) was the recipient of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 177,800 shares, a growth of 45.5% from the May 15th total of 122,200 shares. Approximately 1.0% of the company's stock are short sold. Based on an average daily trading volume, of 167,200 shares, the days-to-cover ratio is currently 1.1 days.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. LPL Financial LLC bought a new position in Nyxoah during the fourth quarter worth about $102,000. Walleye Capital LLC raised its holdings in Nyxoah by 23.9% during the 4th quarter. Walleye Capital LLC now owns 14,831 shares of the company's stock valued at $119,000 after acquiring an additional 2,862 shares during the period. Ameriprise Financial Inc. purchased a new stake in shares of Nyxoah during the fourth quarter worth $135,000. Geode Capital Management LLC lifted its position in shares of Nyxoah by 19.4% during the fourth quarter. Geode Capital Management LLC now owns 17,100 shares of the company's stock worth $137,000 after acquiring an additional 2,774 shares in the last quarter. Finally, Kovack Advisors Inc. boosted its holdings in shares of Nyxoah by 100.0% in the fourth quarter. Kovack Advisors Inc. now owns 20,000 shares of the company's stock worth $160,000 after acquiring an additional 10,000 shares during the period.

Analyst Upgrades and Downgrades

NYXH has been the subject of a number of recent research reports. HC Wainwright reissued a "buy" rating and set a $15.00 price objective on shares of Nyxoah in a report on Tuesday, April 8th. Stifel Nicolaus cut their price target on shares of Nyxoah from $15.00 to $14.00 and set a "buy" rating on the stock in a report on Monday, April 21st.

Nyxoah Stock Performance

NASDAQ NYXH traded down $0.02 during trading hours on Thursday, reaching $7.72. 19,344 shares of the company were exchanged, compared to its average volume of 75,361. The stock has a market capitalization of $262.94 million, a P/E ratio of -3.62 and a beta of 1.65. The company has a quick ratio of 3.35, a current ratio of 3.59 and a debt-to-equity ratio of 0.22. Nyxoah has a 1 year low of $5.55 and a 1 year high of $11.87. The business's 50 day simple moving average is $6.84 and its 200-day simple moving average is $8.43.

Nyxoah (NASDAQ:NYXH - Get Free Report) last posted its quarterly earnings data on Wednesday, May 14th. The company reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.49) by ($0.14). Nyxoah had a negative net margin of 1,571.39% and a negative return on equity of 63.37%. The firm had revenue of $1.12 million during the quarter, compared to analysts' expectations of $1.64 million. On average, equities research analysts expect that Nyxoah will post -1.91 earnings per share for the current year.

Nyxoah Company Profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.